Literature DB >> 3321657

[Prevention of thromboembolism in accident surgery--angiospastic complications with DHE-heparin. A multicenter study].

R Gatterer1, O Wruhs, L Havelec, P Polterauer, L Marosi.   

Abstract

In immobilized patients different drugs are used for thromboembolism prophylaxis. Arterial vasospastic complications have recently been reported after Heparin-DHE. In our clinical observation five of these cases were treated. A multicenter study was performed in 82 Austrian trauma units investigating the incidence and outcome of complications of Heparin DHE prophylaxis. 147,290 patients had different drugs for thromboembolism prophylaxis. 61,092 got Heparin-DHE. Complications could be observed at 142 patients but only in the group receiving Heparin DHE. 135 cases were treated conservatively (amputation of limbs became necessary in seven patients). In seven other cases immediate operative exposure of the vessels and balloon catheter dilatation was successfully performed. Vasospasm occurred only in patients with Heparin DHE prophylaxis. It is important to realize this possibility, so that early therapeutic measurements can be taken to avoid unnecessary permanent ischaemic damages and limb amputation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321657     DOI: 10.1007/BF02588507

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  46 in total

1.  IMPENDING GANGRENE OF FOUR EXTREMITIES SECONDARY TO ERGOTISM.

Authors:  J J CRANLEY; R J KRAUSE; E S STRASSER; C D HAFNER
Journal:  N Engl J Med       Date:  1963-10-03       Impact factor: 91.245

2.  Ergotamine poisoning producing renal arterial spasm.

Authors:  M S Fedotin; C Hartman
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

3.  [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].

Authors:  E van den Berg; G Walterbusch; L Gotzen; K D Rumpf; B Otten; H Fröhlich
Journal:  Vasa       Date:  1983       Impact factor: 1.961

4.  [Ergotism in heparin-dihydroergotamine therapy].

Authors:  H J Schneck; G Tempel; B Kramann
Journal:  Dtsch Med Wochenschr       Date:  1983-03-11       Impact factor: 0.628

5.  [Vasospastic reactions after heparin-dihydroergotamine].

Authors:  K J Paquet
Journal:  Dtsch Med Wochenschr       Date:  1982-09-03       Impact factor: 0.628

6.  Endothelial changes induced by arterial spasm.

Authors:  I Joris; G Majno
Journal:  Am J Pathol       Date:  1981-03       Impact factor: 4.307

7.  Prazosin treatment of ergotamine-induced peripheral ischemia.

Authors:  D S Cobaugh
Journal:  JAMA       Date:  1980-09-19       Impact factor: 56.272

8.  [Lethal pulmonary embolism in traumatology (author's transl)].

Authors:  P Polterauer; P Kohn; M Thien; E Vormittag; F Zekert
Journal:  Unfallheilkunde       Date:  1978-07

Review 9.  Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.

Authors:  A J Comerota; G J Stewart; J V White
Journal:  Am J Surg       Date:  1985-10-08       Impact factor: 2.565

10.  Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70.

Authors:  U F Gruber
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.